Clinical Trials
44 trialsClinical Genetics Branch Eligibility Screening Survey
National Institutes of Health Clinical Center (CC)
Natural History Study of Early Life Exposures in Agriculture (ELEA)
National Institutes of Health Clinical Center (CC)
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
National Institutes of Health Clinical Center (CC)
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma
Xijing Hospital
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
National Institutes of Health Clinical Center (CC)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
SHERLOCK
University Health Network, Toronto
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Eastern Cooperative Oncology Group
iCaRe2
University of Nebraska
Project: Every Child for Younger Patients With Cancer
Children's Oncology Group
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
M.D. Anderson Cancer Center
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
TUPRO
University of Zurich
DP-04
AstraZeneca
ELEPHAS-02
Elephas
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
Dana-Farber Cancer Institute
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ctDNA for Early Detection of Recurrence in Melanoma
Herlev and Gentofte Hospital
CER
Cancer Support Community, Research and Training Institute, Philadelphia
SJFAMILY
St. Jude Children's Research Hospital
MERLIN_001
SkylineDx
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
M.D. Anderson Cancer Center
HELIOPREDICT
Nantes University Hospital
ctDNA for Risk Stratification in Melanoma
Herlev and Gentofte Hospital
TraveraRTGx
Travera Inc
UK-EnBiRiM
Pierre Fabre Ltd
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
COSMIC
Wake Forest University Health Sciences
LEGIT_MC_EVCDA
AI Labs Group S.L
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Ohio State University
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Mayo Clinic
IMMUMELA
Assistance Publique - Hôpitaux de Paris
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Institute of Oncology Ljubljana
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
M.D. Anderson Cancer Center